Stay updated on Pediatric Tesevatinib Safety in ARPKD Clinical Trial
Sign up to get notified when there's something new on the Pediatric Tesevatinib Safety in ARPKD Clinical Trial page.

Latest updates to the Pediatric Tesevatinib Safety in ARPKD Clinical Trial page
- CheckyesterdayChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, while removing specific state, country, and city information.SummaryDifference12%
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.3%
- Check22 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.3%
- Check29 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference4%
- Check36 days agoChange DetectedThe web page has been updated to reflect a new version, changing from Revision v2.16.6 to v2.16.8, and it now includes information about HHS Vulnerability Disclosure.SummaryDifference0.8%
- Check44 days agoChange DetectedThe web page has been updated from version 2.16.5 to version 2.16.6.SummaryDifference0.3%
Stay in the know with updates to Pediatric Tesevatinib Safety in ARPKD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pediatric Tesevatinib Safety in ARPKD Clinical Trial page.